SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 254.64 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 57.83 |
| Book Value / Share | 8.21 |
| Price / Book | n/a |
| NCAV ($M) | 57.65 |
| NCAV / Share | 8.18 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.02 |
| Return on Assets (ROA) | -0.16 |
| Return on Equity (ROE) | -0.18 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 126.15 |
| Current Ratio | 126.15 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 58.22 |
| Assets | 58.40 |
| Liabilities | 0.57 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -2.62 |
| Net Income | -2.80 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -1.85 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.81 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Commodore Capital Lp | |||
| 13G/A | Point72 Asset Management, L.P. | |||
| 13G | Sio Capital Management, LLC | |||
| 13G | Janus Henderson Group Plc | |||
| 13G | Ra Capital Management, L.p. | 6.60 | ||
| 13G/A | Cormorant Asset Management, LP | 17.26 | 24.63 | |
| 13D/A | McDonald Ian | 24.40 | -12.87 | |
| 13G | Logos Global Management LP | 2.20 | ||
| 13G/A | PFM Health Sciences, LP | 0.00 | ||
| 13G | Perceptive Advisors Llc | 9.60 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 12,746 | 59,450 | 21.44 | |
| 4,988 | 54,916 | 9.08 | |
| 24,204 | 96,017 | 25.21 | |
| 8,852 | 68,117 | 13.00 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| DNTH – Dianthus Therapeutics, Inc. | DRMA – Dermata Therapeutics, Inc. |
| DRRX – DURECT Corporation | DTIL – Precision BioSciences, Inc. |
| DWTX – Dogwood Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io